Stockscreener 앱 받기
46.85
0.17%
-0.08
시간 외 거래:
46.85
전일 마감가:
$46.93
열려 있는:
$47.37
하루 거래량:
1.31M
Relative Volume:
1.01
시가총액:
$10.18B
수익:
$1.98B
순이익/손실:
$83.59M
주가수익비율:
125.27
EPS:
0.374
순현금흐름:
$502.31M
1주 성능:
+0.11%
1개월 성능:
+1.83%
6개월 성능:
+16.98%
1년 성능:
+5.24%
1일 변동 폭
$46.45
$47.59
1주일 범위
$46.45
$47.93
52주 변동 폭
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
QGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
46.85 | 10.18B | 1.98B | 83.59M | 502.31M | 0.374 |
|
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-24 | 개시 | Barclays | Overweight |
| 2025-04-04 | 다운그레이드 | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-10-17 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-06-27 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-12-07 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-09-12 | 개시 | Robert W. Baird | Outperform |
| 2023-05-23 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-01-18 | 업그레이드 | DZ Bank | Hold → Buy |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-10-14 | 개시 | Redburn | Buy |
| 2021-07-14 | 다운그레이드 | Kepler | Buy → Hold |
| 2021-06-03 | 개시 | Goldman | Neutral |
| 2020-10-06 | 재개 | BofA Securities | Buy |
| 2020-09-28 | 업그레이드 | Kepler | Hold → Buy |
| 2020-08-24 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-08-17 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-08-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-08-14 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-12-26 | 재개 | BofA/Merrill | Underperform |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-11-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-11-14 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2019-11-14 | 업그레이드 | Kepler | Reduce → Hold |
| 2019-10-17 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | 다운그레이드 | Kepler | Hold → Reduce |
| 2019-10-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-10-08 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
모두보기
Qiagen Nv 주식(QGEN)의 최신 뉴스
Market reaction to Qiagen N.V.’s recent news2025 Market Outlook & Real-Time Buy Zone Alerts - newser.com
How cyclical is Qiagen N.V. (QIA) stock compared to rivalsAnalyst Upgrade & Safe Investment Capital Preservation Plans - newser.com
What technical models suggest about Qiagen N.V.’s comeback2025 Performance Recap & AI Forecast Swing Trade Picks - newser.com
Qiagen N.V. stock daily chart insights2025 Stock Rankings & Long-Term Investment Growth Plans - newser.com
Can Qiagen N.V. (QIA) stock deliver consistent EPS growthTrade Ideas & Daily Stock Trend Reports - newser.com
Price action breakdown for Qiagen N.V.New Guidance & High Conviction Investment Ideas - newser.com
Does Qiagen N.V. Common Shares stock trade below intrinsic value2025 Major Catalysts & Technical Entry and Exit Tips - newser.com
Is TPST a good long term investmentMarket Sentiment Extremes & Free High Profit Capital Plays - earlytimes.in
Qiagen (NYSE:QGEN) Earns Hold (C+) Rating from Weiss Ratings - MarketBeat
OLD National Bancorp IN Buys Shares of 5,277 QIAGEN N.V. $QGEN - MarketBeat
Is Qiagen NV a good long term investmentReal-Time Stock Alerts & Breakthrough Investment Results - earlytimes.in
What analysts say about Qiagen NV stockTake Profit Strategies & Low Risk Capital Growth Plans - earlytimes.in
Qiagen N.V. Announces Voting Rights Notification by AFM - TipRanks
Release according to Article 40, Section 1 of the WpHG - TradingView
What dividend safety score for Qiagen N.V. stockEarnings Miss & Weekly Watchlist of Top Performers - newser.com
How Qiagen N.V. stock reacts to oil pricesJuly 2025 Recap & Capital Efficient Trade Techniques - newser.com
Clifford Chance advises international banking syndicate on $750 million convertible bond issuance of QIAGEN N.V. - Legal Desire Media and Insights
Can Qiagen N.V. (QIA) stock deliver double digit returnsGap Down & Stock Timing and Entry Methods - newser.com
Will Qiagen N.V. stock attract more institutional investorsBond Market & Reliable Price Breakout Signals - newser.com
Will Qiagen N.V. price bounce be sustainableJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - newser.com
Why Qiagen (QGEN) Is Up 6.6% After FDA Clearance and Raised Sales Guidance - Sahm
Why Qiagen N.V. (QIA) stock appears on watchlistsRate Hike & AI Driven Stock Reports - newser.com
How Qiagen N.V. Common Shares stock trades after rate cutsJuly 2025 Short Interest & Weekly Chart Analysis and Guides - newser.com
J. Safra Sarasin Holding AG Purchases Shares of 7,011 QIAGEN N.V. $QGEN - MarketBeat
What Qiagen N.V.'s (NYSE:QGEN) P/S Is Not Telling You - 富途牛牛
111 Capital Purchases Shares of 47,321 Qiagen N.V. $QGEN - MarketBeat
QGEN Collaborates With McGill University Centre: Stock to Gain? - MSN
QIAGEN (NYSE:QGEN) Stock Rating Lowered by Wall Street Zen - MarketBeat
QIAGEN Receives Several Conditional, Non-binding Indications of Interest, Enters Into Discussions to Explore Potential Strate... - ADVFN
How geopolitical risks impact Qiagen N.V. Common Shares stockMarket Movement Recap & Safe Entry Momentum Tips - newser.com
Statistical indicators supporting Qiagen N.V.’s strength2025 Volatility Report & Growth Focused Entry Point Reports - newser.com
Barclays Maintains Qiagen N.V. (QGEN) Overweight Recommendation - Nasdaq
Qiagen (QGEN) Analyst Maintains Rating But Lowers Price Target | - GuruFocus
Qiagen Nv (QGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.17%
2.19%
자본화:
|
볼륨(24시간):